Melanotan II is a non-selective agonist of melanocortin receptors, particularly MC3 and MC4, which activates signaling pathways involved in skin pigmentation (melanogenesis), appetite regulation, and sexual arousal. The activation of these receptors influences the proopiomelanocortin (POMC) pathway, leading to increased α-MSH production, which modulates feeding behavior and stimulates oxytocin neuronal activity in the hypothalamus. The precise molecular mechanisms underlying its systemic toxicity and effects on renal function remain incompletely understood.